Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 1.05% is 67% below its 5-year average of 3.23%, near the low end of its 5-year range (-1.04%–15.09%).
6.83% below its 12-month average of 1.13%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.03%.
NET PROFIT MARGIN
1.05%
NET PROFIT MARGIN AVG TTM
1.13%
NET PROFIT MARGIN AVG 3Y
2.33%
NET PROFIT MARGIN AVG 5Y
3.23%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.83%
CURRENT VS 3Y AVG
-54.89%
CURRENT VS 5Y AVG
-67.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 431 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Astrana Health, Inc.
Market Cap
$1.83B
Net Profit Margin
1.05%
TTM Avg
1.13%
3Y Avg
2.33%
5Y Avg
3.23%
Market Cap
$1.87B
Net Profit Margin
-418.24%
TTM Avg
540.96%
3Y Avg
-464.63%
5Y Avg
-309.76%
Market Cap
$1.78B
Net Profit Margin
-636.99%
TTM Avg
-743.17%
3Y Avg
-743.17%
5Y Avg
-743.17%
Market Cap
$1.78B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$1.89B
Net Profit Margin
49.06%
TTM Avg
-18.57%
3Y Avg
-80.13%
5Y Avg
-53.74%
Market Cap
$1.76B
Net Profit Margin
0.89%
TTM Avg
-2.38%
3Y Avg
-5.83%
5Y Avg
-7.07%
Market Cap
$1.71B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.95B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
Market Cap
$1.96B
Net Profit Margin
-15.82%
TTM Avg
-37.57%
3Y Avg
-42.30%
5Y Avg
-41.11%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Astrana Health, Inc. (ASTH) | $1.83B | 1.05% | 1.13% | 2.33% | 3.23% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -418.24% | 540.96% | -464.63% | -309.76% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -636.99% | -743.17% | -743.17% | -743.17% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -672.16% | -753.31% | -935.73% | -797.48% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 49.06% | -18.57% | -80.13% | -53.74% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 0.89% | -2.38% | -5.83% | -7.07% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -14.99% | -20.12% | -16.95% | -10.04% |
| Absci Corporation (ABSI)vs › | $1.95B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -15.82% | -37.57% | -42.30% | -41.11% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -20.02% | -19.08% | -29.38% | -13.21% |
Operating Margin
2.6%
Net Profit Margin
1.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 2.03% |
| 2026-03-31 | 1.50% |
| 2025-12-31 | 0.63% |
| 2025-09-30 | 0.04% |
| 2025-06-30 | 1.44% |
| 2025-03-31 | 1.08% |
| 2024-12-31 | -1.04% |
| 2024-09-30 | 3.36% |
| 2024-06-30 | 3.94% |
| 2024-03-31 | 3.67% |
| 2023-12-31 | 3.50% |
| 2023-09-30 | 6.34% |
| 2023-06-30 | 3.78% |
| 2023-03-31 | 3.89% |
| 2022-12-31 | -0.88% |
| 2022-09-30 | 7.31% |
| 2022-06-30 | 4.43% |
| 2022-03-31 | 5.23% |
| 2021-12-31 | 7.06% |
| 2021-09-30 | 15.09% |
| 2021-06-30 | 7.21% |
